TrialJAMA ophthalmology2019

Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.

David W Hutton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.